EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:754385 |
| ChEBI Name | bermekimab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsoriatic A drug used to treat psoriasis. anti-inflammatory agent Any compound that has anti-inflammatory effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bermekimab (CHEBI:754385) has role anti-inflammatory agent (CHEBI:67079) |
| bermekimab (CHEBI:754385) has role antineoplastic agent (CHEBI:35610) |
| bermekimab (CHEBI:754385) has role antipsoriatic (CHEBI:50748) |
| bermekimab (CHEBI:754385) has role dermatologic drug (CHEBI:50177) |
| bermekimab (CHEBI:754385) has role hypoglycemic agent (CHEBI:35526) |
| bermekimab (CHEBI:754385) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Bermekimab | ChEMBL |
| CA-18C3 | ChEMBL |
| CV-18C3 | ChEMBL |
| MaBp1 | ChEMBL |
| RA-18C3 | ChEMBL |
| T2-18C3 | ChEMBL |
| Brand Name | Source |
|---|---|
| Xilonix | ChEMBL |